Buying Lunch Might Help Drug Makers Win Over Doctors Who Have Little Reason to Prescribe Their Brand – Forbes

Read article - Quotes Steven Woloshin, professor of medicine, community and family medicine, and of the Dartmouth Institute for Health Policy and Clinical Practice, about a new study that found that doctors who accepted even a single free lunch (or, for that matter, free dinner) from pharmaceutical companies were more likely to prescribe their host’s pricey brand-name drug to Medicare beneficiaries instead of a cheaper, equally effective generic alternative. Woloshin was not involved in the study.